72 related articles for article (PubMed ID: 17329481)
1. Confounding by indication and the risk of hyperlipidemia in observational studies of antipsychotics.
Rico-Villademoros F; Calandre EP
Am J Psychiatry; 2007 Mar; 164(3):525-6; author reply 526. PubMed ID: 17329481
[No Abstract] [Full Text] [Related]
2. Severe hyperlipidemia associated with olanzapine and quetiapine use.
Carnahan RM; Reantaso AA; Teegarden BA; Pogue T
Am J Psychiatry; 2007 Oct; 164(10):1614-5. PubMed ID: 17898359
[No Abstract] [Full Text] [Related]
3. Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels.
de Leon J; Correa JC; Ruaño G; Windemuth A; Arranz MJ; Diaz FJ
Schizophr Res; 2008 Jan; 98(1-3):40-6. PubMed ID: 18031993
[TBL] [Abstract][Full Text] [Related]
4. Hyperlipidemia following treatment with antipsychotic medications.
Olfson M; Marcus SC; Corey-Lisle P; Tuomari AV; Hines P; L'Italien GJ
Am J Psychiatry; 2006 Oct; 163(10):1821-5. PubMed ID: 17012695
[TBL] [Abstract][Full Text] [Related]
5. Dyslipidemia and atypical antipsychotic drugs.
Casey DE
J Clin Psychiatry; 2004; 65 Suppl 18():27-35. PubMed ID: 15600382
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of atypical antipsychotics in patients with Alzheimer's dementia. CATIE-AD-Study (Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer's Disease)].
Förstl H
Internist (Berl); 2007 Jun; 48(6):642-4. PubMed ID: 17497111
[No Abstract] [Full Text] [Related]
7. Olanzapine and pediatric bipolar disorder: evidence for efficacy and safety concerns.
McClellan JM
Am J Psychiatry; 2007 Oct; 164(10):1462-4. PubMed ID: 17898331
[No Abstract] [Full Text] [Related]
8. Risperidone alternative for a schizophrenic patient with olanzapine-exacerbated diabetic mellitus.
Wu PL; Lane HY; Su KP
Psychiatry Clin Neurosci; 2006 Feb; 60(1):115-6. PubMed ID: 16472369
[No Abstract] [Full Text] [Related]
9. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
van Marum RJ; Jansen PA
Ned Tijdschr Geneeskd; 2005 Jan; 149(4):165-7. PubMed ID: 15702733
[TBL] [Abstract][Full Text] [Related]
10. Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study.
Tenback DE; van Harten PN; Slooff CJ; Belger MA; van Os J;
J Clin Psychiatry; 2005 Sep; 66(9):1130-3. PubMed ID: 16187770
[TBL] [Abstract][Full Text] [Related]
11. Ziprasidone and mania.
Ross DE
Am J Psychiatry; 2004 Aug; 161(8):1503. PubMed ID: 15285991
[No Abstract] [Full Text] [Related]
12. [Mortality and cumulative exposure to antipsychotics, antidepressants and benzodiazepines in patients with schizophrenia: an observational follow-up study].
Tiihonenl J; Mittendorfer-Rutz E; Torniainen M; Alexanderson K; Tanskanen A
Duodecim; 2016; 132(2):181. PubMed ID: 26939492
[No Abstract] [Full Text] [Related]
13. Atypical antipsychotics and risk of cerebrovascular accidents.
Herrmann N; Mamdani M; Lanctôt KL
Am J Psychiatry; 2004 Jun; 161(6):1113-5. PubMed ID: 15169702
[TBL] [Abstract][Full Text] [Related]
14. The effects of antipsychotic therapy on serum lipids: a comprehensive review.
Meyer JM; Koro CE
Schizophr Res; 2004 Sep; 70(1):1-17. PubMed ID: 15246458
[TBL] [Abstract][Full Text] [Related]
15. [Cerebral infarct and atypical antipsychotic agents].
Lacomblez L
Psychol Neuropsychiatr Vieil; 2004 Dec; 2(4):299. PubMed ID: 15706675
[No Abstract] [Full Text] [Related]
16. Methodological concerns in a trial of ziprasidone and olanzapine.
Ross DE
Am J Psychiatry; 2005 Jul; 162(7):1391; author reply 1391-2. PubMed ID: 15994735
[No Abstract] [Full Text] [Related]
17. Methodological concerns in a trial of ziprasidone and olanzapine.
Carnahan RM; Perry PJ
Am J Psychiatry; 2005 Jul; 162(7):1391; author reply 1391-2. PubMed ID: 15994736
[No Abstract] [Full Text] [Related]
18. Exploring the risk of diabetes mellitus and dyslipidemia among ambulatory users of atypical antipsychotics: a population-based comparison of risperidone and olanzapine.
Moisan J; Grégoire JP; Gaudet M; Cooper D
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):427-36. PubMed ID: 15786513
[TBL] [Abstract][Full Text] [Related]
19. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.
Layton D; Harris S; Wilton LV; Shakir SA
J Psychopharmacol; 2005 Sep; 19(5):473-82. PubMed ID: 16166184
[TBL] [Abstract][Full Text] [Related]
20. Atypical antipsychotics for the treatment of delirious elders.
Ozbolt LB; Paniagua MA; Kaiser RM
J Am Med Dir Assoc; 2008 Jan; 9(1):18-28. PubMed ID: 18187109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
